Genetics of Wilson disease and Wilson-like phenotype in a clinical series from eastern Spain
Autores de CIPF
Participantes ajenos a CIPF
- Alvarez-Sauco, M
- Sastre, I
- Martinez-Torres, I
- Berenguer, M
Grupos de Investigación
Abstract
Wilson's disease (WD) is an autosomal recessive disorder caused by ATP7B mutations. Subjects with only one mutation may show clinical signs and individuals with biallelic changes may remain asymptomatic. We aimed to achieve a conclusive genetic diagnosis for 34 patients clinically diagnosed of WD. Genetic analysis comprised from analysis of exons to WES (whole exome sequencing), including promoter, introns, UTRs (untranslated regions), besides of study of large deletions/duplications by MLPA (multiplex ligation-dependent probe amplification). Biallelic ATP7B mutations were identified in 30 patients, so that four patients were analyzed using WES. Two affected siblings resulted to be compound heterozygous for mutations in CCDC115, which is involved in a form of congenital disorder of glycosylation. In sum, the majority of patients with a WD phenotype carry ATP7B mutations. However, if genetic diagnosis is not achieved, additional genes should be considered because other disorders may mimic WD.
Datos de la publicación
- ISSN/ISSNe:
- 0009-9163, 1399-0004
- Tipo:
- Article
- Páginas:
- 758-763
- DOI:
- 10.1111/cge.13719
- PubMed:
- 32043565
CLINICAL GENETICS WILEY
Citas Recibidas en Web of Science: 24
Documentos
- No hay documentos
Filiaciones
Keywords
- ATP7B gene; CCDC115 gene; genetic diagnosis; targeted next-generation sequencing; whole exome sequencing; Wilson's disease; Wilson-like phenotype
Proyectos asociados
An integrative approach to develop cellular models and characterize disease mechanisms implicated in CMT2Z, a newly described axonal form of neuropathy
Investigador Principal: CARMEN ESPINÓS ARMERO
ASSOCIATION FRANÇAISE CONTRE LES MYOPATHIES . 2018
Estudios clínicos, bases genéticas y biomarcadores pronósticos en enfermedades raras neurodegenerativas
Investigador Principal: CARMEN ESPINÓS ARMERO
INSTITUTO DE SALUD CARLOS III . 2019
Identificación de nuevas causas genéticas en pacientes con neuropatías periféricas hereditarias y difícil diagnóstico genético
Investigador Principal: VINCENZO LUPO
CONSELLERIA DE EDUCACION . 2019
Caracterización de nuevos genes y biomarcadores proteicos para avanzar en el diagnóstico, prognosis y terapia de la neuropatía axonal hereditaria (CMT2)
Investigador Principal: VINCENZO LUPO
INSTITUTO DE SALUD CARLOS III . 2020
De genes a terapia en enfermedades neurodegenerativas y neuromusculares. Concedido a la UV
Investigador Principal: CARMEN ESPINÓS ARMERO
CONSELLERIA DE EDUCACION . 2018